EP 1183371 A2 20020306 - COMPOSITION DESIGNED FOR IMPLEMENTING AN ANTITUMORAL OR ANTIVIRAL TREATMENT IN A MAMMAL
Title (en)
COMPOSITION DESIGNED FOR IMPLEMENTING AN ANTITUMORAL OR ANTIVIRAL TREATMENT IN A MAMMAL
Title (de)
ZUSAMMENSETZUNG ZUR DURCHFÜHRUNG EINER ANTITUMORALEN ODER ANTIVIRALEN BEHANDLUNG IN EINEM SÄUGETIER
Title (fr)
COMPOSITION DESTINEE A LA MISE EN OEUVRE D'UN TRAITEMENT ANTITUMORAL OU ANTIVIRAL CHEZ UN MAMMIFERE
Publication
Application
Priority
- FR 0001422 W 20000525
- FR 9906892 A 19990525
Abstract (en)
[origin: FR2794025A1] The invention concerns a composition for implementing an antitumoral or antiviral treatment in a mammal comprising: (i) a nucleic acid sequence coding for all or part of polypeptide p53; (ii) at least a nucleic acid sequence coding for all or part of a polypeptide having at least a cytotoxic activity, said nucleic acid sequences being placed under the control of elements required for their expression in a host cell of said mammal.
IPC 1-7
C12N 15/54; C12N 15/12; A61K 48/00; A61K 38/17; A61K 38/45; A61P 35/00; A61P 31/12
IPC 8 full level
C12N 15/09 (2006.01); C12N 15/54 (2006.01); A61K 31/513 (2006.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 38/45 (2006.01); A61K 48/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); C12N 7/00 (2006.01); C12N 7/02 (2006.01); C12N 15/12 (2006.01); C12N 15/861 (2006.01)
CPC (source: EP)
A61K 31/513 (2013.01); A61K 38/2013 (2013.01); A61K 38/217 (2013.01); A61P 31/12 (2018.01); A61P 35/00 (2018.01); C12N 15/86 (2013.01); A61K 48/00 (2013.01); C12N 2710/10343 (2013.01); C12N 2840/203 (2013.01)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
FR 2794025 A1 20001201; AU 4931400 A 20001212; AU 774391 B2 20040624; CA 2374941 A1 20001130; EP 1183371 A2 20020306; HK 1046426 A1 20030110; JP 2003500342 A 20030107; WO 0071078 A2 20001130; WO 0071078 A3 20010419
DOCDB simple family (application)
FR 9906892 A 19990525; AU 4931400 A 20000525; CA 2374941 A 20000525; EP 00931350 A 20000525; FR 0001422 W 20000525; HK 02106412 A 20020829; JP 2000619390 A 20000525